Form 4 for BSX Boston Scientific
Accepted 2023-03-02 00:00:00 ET · period of report 2023-03-01 · accession 0001225208-23-003166 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-02 | 2023-03-01+ | BSX | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $46.65 | -105.6K | 226.0K | -32% | -$4.93M |
| DM | 2023-03-02 | 2023-03-01 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $15.69 | +45.6K | 331.6K | +16% | +$715.8K |
| DM | 2023-03-02 | 2023-03-01 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | -45.6K | 13.7K | -77% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | S | D | 75,610 | $46.64 | 255,958 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.437 to $46.80, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-03-02 | S | D | 30,000 | $46.66 | 225,958 | D | — | — | (F3) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.575 to $46.74, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-03-01 | M | A | 16,863 | $17.26 | 302,821 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-01 | M | A | 15,086 | $16.31 | 317,907 | D | — | — | |
| 5 | Common | Common Stock | 2023-03-01 | M | A | 13,661 | $13.08 | 331,568 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-03-01 | M | D | 16,863 | $0.00 | 33,728 | D | $17.26 · — to 2026-02-22 | 16,863 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-03-01 | M | D | 15,086 | $0.00 | 30,173 | D | $16.31 · — to 2025-02-23 | 15,086 Common Stock | (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-03-01 | M | D | 13,661 | $0.00 | 13,662 | D | $13.08 · — to 2024-02-24 | 13,661 Common Stock | (F6) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. |